ATP6V1E2 has not been detected as a mutational cancer driver in this cancer type
| Uterine corpus endometrioid carcinoma |
|---|
|
Projects
1
230 Samples |
|
Coding sequence mutations (CSMs) in driver genes 1784 in all genes 68806 |
|
Protein affecting mutations (PAMs) in driver genes 1591 in all genes 34136 |
| ATP6V1E2 |
|---|
| Ensembl id ENSG00000250565 |
| Mutated samples
Coding Sequence 1 (0.4%) Protein Affecting 1 (0.4%) |
| Mode of action Unclassified |
| Known driver No |
| Project | Signals |
|---|
Clust Clustered Mutations FM Functional Mutations Rec Recurrent Mutations
This plot shows the most recurrently mutated Uterine corpus endometrioid carcinoma projects in all ATP6V1E2 gene mutations. Each bar of the histogram indicates the amount of samples with PAMs.
| Project | Driver | Mutated samples (CS) | Mutated samples (PAM) | % Mutated samples (PAM) |
|---|---|---|---|---|
| Uterine corpus endometrioid carcinoma TCGA | No | 1 | 1 | 0.43 |
Choose a transcript:
The mutations needle plot shows the distribution of the observed ATP6V1E2 cancer mutations along the protein sequence and it's possible mutational clusters and hotspots. The needles' height and head size represent mutational recurrence. Needles of different categories that fall in the same amino acid residues are stacked.
| Variant Locus | Samples | AA pos | AA change | Consequence | Driver classification |
|---|